drugset / Trial / NCT04520386
OMT-111 for Terminal Stage Solid Tumors
NaSingle-groupOpen-labelTreatment
Summary
Patients with terminal stage of metastatic non-small cell lung cancer, metastatic triple negative breast cancer, or advanced or metastatic pancreatic adenocarcinoma resisting to standard therapies.
Timeline
- Start
- 2020-10
- Primary completion
- 2022-06-30
- Completion
- 2022-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | OMT-111 | Unknown | — | — |